TY - JOUR
T1 - Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo
AU - Suda, Koichi
AU - Takeuchi, Hiroya
AU - Hagiwara, Tomoko
AU - Miyasho, Taku
AU - Yamada, Shingo
AU - Inoue, Takehiro
AU - Okamoto, Minoru
AU - Wada, Norihito
AU - Saikawa, Yoshirou
AU - Fukunaga, Koichi
AU - Hashimoto, Satoru
AU - Yokota, Hiroshi
AU - Maruyama, Ikuro
AU - Kitagawa, Yuko
PY - 2010/5
Y1 - 2010/5
N2 - High-mobility-group box chromosomal protein 1 (HMGB1) has recently been identified as a late mediator of various kinds of acute and chronic inflammation. A method for efficiently removing HMGB1 from systemic circulation could be a promising therapy for HMGB1-mediated inflammatory diseases. It is well known that the cationic portion of HMGB1 binds to heparin, which has abundant sulfates in its structure. In this study, we determined whether spherical sulfated cellulose (SC) efficiently adsorbed HMGB1, as well as other inflammatory mediators, in vitro. Then, we investigated the efficacy of hemoperfusion with the SC (SC group) or cellulose beads (control group) at adsorbing endogenous mediators, including HMGB1, in vivo. We have demonstrated that the SC adsorbed significantly larger amounts of HMGB1, interleukin (IL)-4, and IL-8 when compared with cellulose beads, in vitro. Hemoperfusion with the SC for 30 minute, starting 2 hour after an abdominal opening and closure operation, significantly reduced serum HMGB1 levels (p = 0.004) and consistently increased serum IL-10 levels, in vivo. These data suggest the potential benefits of hemoperfusion using the SC in treating HMGB1-mediated inflammatory diseases.
AB - High-mobility-group box chromosomal protein 1 (HMGB1) has recently been identified as a late mediator of various kinds of acute and chronic inflammation. A method for efficiently removing HMGB1 from systemic circulation could be a promising therapy for HMGB1-mediated inflammatory diseases. It is well known that the cationic portion of HMGB1 binds to heparin, which has abundant sulfates in its structure. In this study, we determined whether spherical sulfated cellulose (SC) efficiently adsorbed HMGB1, as well as other inflammatory mediators, in vitro. Then, we investigated the efficacy of hemoperfusion with the SC (SC group) or cellulose beads (control group) at adsorbing endogenous mediators, including HMGB1, in vivo. We have demonstrated that the SC adsorbed significantly larger amounts of HMGB1, interleukin (IL)-4, and IL-8 when compared with cellulose beads, in vitro. Hemoperfusion with the SC for 30 minute, starting 2 hour after an abdominal opening and closure operation, significantly reduced serum HMGB1 levels (p = 0.004) and consistently increased serum IL-10 levels, in vivo. These data suggest the potential benefits of hemoperfusion using the SC in treating HMGB1-mediated inflammatory diseases.
UR - http://www.scopus.com/inward/record.url?scp=77952008905&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952008905&partnerID=8YFLogxK
U2 - 10.1097/MAT.0b013e3181d68fa4
DO - 10.1097/MAT.0b013e3181d68fa4
M3 - Article
C2 - 20335795
AN - SCOPUS:77952008905
SN - 1058-2916
VL - 56
SP - 210
EP - 214
JO - ASAIO Journal
JF - ASAIO Journal
IS - 3
ER -